Highlights
- Sales over the Year and quarter:
- Income over the Year and quarter:
- Profit over the Year and quarter: Challenges in sustaining profitability for KOBO BIOTECH LIMITED. Profit dropped by -29.95 % Year to Year, KOBO BIOTECH LIMITED’s profitability increased by 2.03 % in this quarter.
- EPS over the Year and quarter: EPS declined by -29.33 % Year to Year. EPS increased by 1.92 % in previous quarter. Positive impact on shareholders.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 0 Cr | Rs. 0 Cr | Rs. 0 Cr | 0 % | 0 % |
| Expenses | Rs. 0.79 Cr | Rs. 0.2 Cr | Rs. 0.25 Cr | + 25 % | -68.35 % |
| Operating Profit | Rs. -0.79 Cr | Rs. -0.2 Cr | Rs. -0.25 Cr | -25 % | + 68.35 % |
| OPM % | 0 % | 0 % | 0 % | 0 % | 0 % |
| Other Income | Rs. 0 Cr | Rs. 0 Cr | Rs. -0 Cr | 0 % | 0 % |
| Interest | Rs. 0 Cr | Rs. 0 Cr | Rs. 0 Cr | 0 % | 0 % |
| Depreciation | Rs. 1 Cr | Rs. 1.03 Cr | Rs. 1.01 Cr | -1.94 % | + 1 % |
| Profit before tax | Rs. -1.79 Cr | Rs. -1.23 Cr | Rs. -1.26 Cr | -2.44 % | + 29.61 % |
| Tax % | -0 % | -0 % | -0 % | 0 % | 0 % |
| Net Profit | Rs. -1.79 Cr | Rs. -1.23 Cr | Rs. -1.26 Cr | -2.44 % | + 29.61 % |
| EPS in Rs | Rs. -0.75 | Rs. -0.52 | Rs. -0.53 | -1.92 % | + 29.33 % |
Today, we’re looking at KOBO BIOTECH LIMITED’s financial performance for the Q4(Mar 2024).Expenses ticked up slightly by 25 % quarter-on-quarter, aligning with the annual decline of -68.35 %. Operating profit, while up 68.35 % compared to last year, faced a quarter-on-quarter dip of -25 %, signaling a short-term contraction in margins.
Depreciation costs fell by -1.94 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 1 %. Profit before tax grew annually by 29.61 % but saw a reduction from the preceding quarter by -2.44 %.
Net profit rose by 29.61 % year-on-year but witnessed a -2.44 % contraction from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 29.33 % but a quarterly fall of -1.92 %. In summary, KOBO BIOTECH LIMITED’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 0 Cr | Rs. 0 Cr | Rs. 0 Cr | 0 % | 0 % |
| Expenses | Rs. 0.79 Cr | Rs. 0.2 Cr | Rs. 0.25 Cr | + 25 % | -68.35 % |
| Operating Profit | Rs. -0.79 Cr | Rs. -0.2 Cr | Rs. -0.25 Cr | -25 % | + 68.35 % |
| Net Profit | Rs. -1.79 Cr | Rs. -1.23 Cr | Rs. -1.26 Cr | -2.44 % | + 29.61 % |
| EPS in Rs | Rs. -0.75 | Rs. -0.52 | Rs. -0.53 | -1.92 % | + 29.33 % |
In reviewing KOBO BIOTECH LIMITED’s 2024(Q4) financial snapshot, key trends emerge, shedding light on the company’s performance.Expenses decreased by -68.35 % compared to the previous year, with a 25 % increase quarter-on-quarter. Operating Profit surged by 68.35 % annually, and saw a -25 % decrease from the last quarter.
Net Profit showed yearly increase of 29.61 %, and experienced a -2.44 % decrease from the previous quarter. Earnings Per Share (EPS) rose by 29.33 % annually, however dipped by -1.92 % compared to the last quarter. In essence, while KOBO BIOTECH LIMITED exhibits strong annual growth indicators, short-term fluctuations suggest the need for agile strategies to navigate market dynamics effectively. That’s all for now in the financial sector.
